Management and financials
CVR: 14536604
DKK 0
Gross profit
Net result: DKK 13,153,000
No owners listed
CVR · view owners
Board: Tyge Jesper Rothe (chair) and 2 members
CVR · view management
Active
Founded 16 October 1999
CVR · view overview
0 employees
CVR · 2001
Name registered: CAND.PHARM. POVL M. ASSENS FOND
CVR · 16/10/1999
View the full event history
CAND.PHARM. POVL M. ASSENS FOND is a Danish company of the type Erhvervsdrivende fond based in Glostrup, founded in 1999. The company is registered under the industry Støtteaktiviteter relateret til sygdomsbekæmpende, sociale og velgørende formål. The board consists of Tyge Jesper Rothe (chair), Niels Christian Assens and Søren Wang Petersen. The company has 0 employees (2001). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 13,153,000 compared with DKK 11,790,112 the year before. Equity in the 2025 report amounted to DKK 128,614,000.
Fondens formål er: 1. at drive erhvervsvirksomhed, herunder, sålænge bestyrelsen finder det rigtigt, helt eller delvis at eje aktiekapitalen i Biofarma Logistik A/S og om fornødent yde støtte til driften af denne virksomhed 2. at støtte de medicinsk historiske og pharmaceutisk historiske videnskaber og museumsvirksomhed indenfor disse områder 3. i øvrigt at støtte videnskabelige formål
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | 13.2M | 131.1M | 128.6M | 56 | |
| 202401/01/2024 – 31/12/2024 | 0 | 11.8M | 120.1M | 117.5M | 52 | |
| 202301/01/2023 – 31/12/2023 | 0 | 7.1M | 110M | 107.1M | 53 | |
| 202201/01/2022 – 31/12/2022 | - | -3.3M | 105M | 101.7M | 47 | |
| 202101/01/2021 – 31/12/2021 | 0 | 7.3M | 110.3M | 106.1M | 41 | |
| 202001/01/2020 – 31/12/2020 | 0 | 145K | 104M | 101.2M | 37 | |
| 201901/01/2019 – 31/12/2019 | 0 | 4.9M | 104.3M | 102.9M | 36 | |
| 201801/01/2018 – 31/12/2018 | 0 | -1.7M | 100.3M | 98.9M | 36 | |
| 201701/01/2017 – 31/12/2017 | 0 | 5.2M | 103.2M | 101.6M | 32 | |
| 201601/01/2016 – 31/12/2016 | 0 | 5.1M | 99.3M | 97.2M | 29 | |
| 201501/01/2015 – 31/12/2015 | 0 | 6.2M | 96M | 89.2M | 31 | |
| 201401/01/2014 – 31/12/2014 | 0 | 6.9M | 90.2M | 86.3M | - | |
| 201301/01/2013 – 31/12/2013 | 0 | 3.9M | 84.5M | 82.4M | 28 |
Compared to 575 companies in Støtteaktiviteter relateret til sygdomsbekæmpende, sociale og velgørende formål
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of CAND.PHARM. POVL M. ASSENS FOND is 14536604.
The board of CAND.PHARM. POVL M. ASSENS FOND consists of Tyge Jesper Rothe, Niels Christian Assens and Søren Wang Petersen, with Tyge Jesper Rothe as chair.
In 2025, CAND.PHARM. POVL M. ASSENS FOND reported a gross profit of DKK 0.
CAND.PHARM. POVL M. ASSENS FOND had 0 employees in 2001 according to the Danish CVR register.
CAND.PHARM. POVL M. ASSENS FOND was founded on 16 October 1999.
CAND.PHARM. POVL M. ASSENS FOND is registered under the industry Støtteaktiviteter relateret til sygdomsbekæmpende, sociale og velgørende formål (industry code 889910).
Claim this page to add your logo and social links. Free to get started.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2025. Gross profit came to DKK 0, and the net result was DKK 13,153,000.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK 11,790,112.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK 7,149,344.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2022. The net result was DKK -3,324,757.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK 7,306,072.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2020. Revenue came to DKK 0, and the net result was DKK 145,131.
As of August 14, 2020, Tyge Jesper Rothe has joined the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of August 14, 2020, Søren Wang Petersen has joined the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of August 14, 2020, Ole Kondrup has left the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of August 13, 2020, Tyge Jesper Rothe has left the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2019. Revenue came to DKK 0, and the net result was DKK 4,924,086.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK -1,737,723.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2017. Revenue came to DKK 0, and the net result was DKK 5,195,201.
As of November 21, 2017, Ole Kilsgaard has left the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2016. Revenue came to DKK 0, and the net result was DKK 5,087,572.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2015. Revenue came to DKK 0, and the net result was DKK 6,215,620.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2014. Revenue came to DKK 0, and the net result was DKK 6,929,662.
As of February 27, 2015, EY Godkendt Revisionspartnerselskab has been appointed auditor of CAND.PHARM. POVL M. ASSENS FOND.
As of February 27, 2015, JUT NR. 2180 A/S has stepped down as auditor of CAND.PHARM. POVL M. ASSENS FOND.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2013. Revenue came to DKK 0, and the net result was DKK 3,928,348.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2012.
As of May 26, 2012, JUT NR. 2180 A/S has been appointed auditor of CAND.PHARM. POVL M. ASSENS FOND.
As of May 26, 2012, EY Danmark A/S has stepped down as auditor of CAND.PHARM. POVL M. ASSENS FOND.
As of December 10, 2004, Tyge Jesper Rothe has joined the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of December 10, 2004, Allan Philip has left the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
CAND.PHARM. POVL M. ASSENS FOND was founded on October 16, 1999.
As of September 30, 1992, Povl Michael Assens has left the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of August 21, 1990, EY Danmark A/S has been appointed auditor of CAND.PHARM. POVL M. ASSENS FOND.
As of August 21, 1990, Allan Philip has joined the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of August 21, 1990, Povl Michael Assens has joined the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of August 21, 1990, Ole Kondrup has joined the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of August 21, 1990, Ole Kilsgaard has joined the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of August 21, 1990, Niels Christian Assens has joined the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
Companies in the same industry and area
CVR 11579442
CVR 85842412
CVR 16540714
CVR 11608574
CVR 10480744